PharmaPlanter operates a versatile, research-grade platform that integrates advanced genomic tools with synthetic biology to engineer specialized cell factories and novel biological molecules. We focus on the precise manipulation of genetic pathways to facilitate early-stage proof-of-concept studies.

Our platform enables:

• Precision Genome Engineering: Utilizing CRISPR/Cas9 and related technologies, we perform targeted gene knockouts, insertions, and modifications in various host systems (microbial and mammalian) to optimize cellular chassis for specific research goals.

• Pathway Design & Optimization: We apply synthetic biology principles to redesign complex metabolic pathways. By fine-tuning enzyme expression levels, we improve the synthesis of high-value secondary metabolites and specialized biomolecules.

• Custom Vector Development: Our platform specializes in designing and constructing high-efficiency expression vectors. We optimize promoters, enhancers, and regulatory elements to ensure stable and controlled gene expression tailored to specific experimental environments.

• Research-Scale Process Validation: We provide preliminary validation of biosynthetic processes at the laboratory scale. Through high-throughput screening and metabolite profiling, we evaluate how different editing strategies impact product yield and quality.

• Supporting Translational Proof-of-Concept: Designed for startups and academic labs, our platform provides the technical infrastructure needed to rapidly test scientific hypotheses and turn innovative biosynthetic concepts into viable experimental models.